Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Schizophrenia
Clinical trial register · China

Schizophrenia Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19212 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
19212
Studies in scope
all four open statuses
11805
Recruiting now
open to new participants
2029
Lead sponsors
across recruiting studies
Top sites
Changsha 11 Beijing 8 Shanghai 8 Tianjin 4 Hefei 3
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
China Medical University Hospital7 Central South University7 Shanghai Mental Health Center7 Vigonvita Life Sciences3 Luye Pharma Group Ltd.3
Site location
Changsha11 Beijing8 Shanghai8 Tianjin4 Hefei3
All 24 locations
Target enrolment
to

Schizophrenia trials in China

46 of 19212 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Chinese University of Hong Kong
Not applicable
228
Chengdu
2027-07-01
Not yet open
Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications
NCT07444463Schizophrenia, Bipolar Disorder, Major Depressive Disorder (MDD)
Central South University
Not applicable
400
Changsha
2027-01-01
Not yet open
Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.
Phase 1
88
Changsha, Xi'an, Shanghai, Huzhou
2026-11-15
Recruiting
The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain
NCT07795554Schizophrenia Spectrum, Schizophrenia, Antipsychotic Induced Weight Gain
Second Xiangya Hospital of Central South University
Not applicable
60
Changsha
2026-11-01
Not yet open
Anhui Medical University
Not applicable
100
Hefei
2026-11-01
Recruiting
tACS for Working Memory in Schizophrenia
NCT07701343Schizophrenia, Working Memory
Central South University
Not applicable
30
Changsha
2026-10-26
Recruiting
Second Xiangya Hospital of Central South University
Not applicable
30
Changsha
2026-10-01
Not yet open
Xingqi Daozhi Decoction for Antipsychotic-Induced Constipation
NCT07767526Schizophrenia, Antipsychotic Drug
Shanghai Mental Health Center
Phase 1/2
46
Shanghai
2026-10-01
Not yet open
Vigonvita Life Sciences
Phase 2
500
Beijing
2026-07-31
Not yet open
Taizhou Second People's Hospital
Observational
200
Taizhou
2026-06-15
Recruiting
The University of Hong Kong
Observational
178
Hong Kong
2026-05-21
Recruiting
Shanghai Mental Health Center
Not applicable
84
Shanghai
2026-04-19
Recruiting
Shanghai Mental Health Center
Not applicable
84
Shanghai
2026-04-19
Not yet open
Luye Pharma Group Ltd.
Phase 2
160
Beijing
2026-03-31
Recruiting
Eli Lilly and Company
Phase 2
450
Changsha, Chengdu, Hangzhou, Suzhou, Tianjin, Wuhu, Xi'an, Zhumadian
2026-02-10
Recruiting
Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders
NCT07479758Major Depressive Disorder (MDD), Schizophrenia, Bipolar Disorder, Severe Mental Disorders
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
320
Hangzhou
2025-11-01
Recruiting
Personalized iTBS in Real-World Clinical Settings for Schizophrenia
NCT07176468Schizophrenia, Transcranial Magnetic Stimulation
Anhui Medical University
Not applicable
40
Hefei
2025-10-20
Active, closed
Qilu Pharmaceutical Co., Ltd.
Phase 3
402
Jinan
2025-10-02
Not yet open
Jiangsu Province Nanjing Brain Hospital
Phase 4
120
Nanjing
2025-10
Recruiting
China Medical University Hospital
Phase 2
90
2025-09-16
Recruiting
A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
NCT07230652Schizophrenia, Alzheimer's Disease Psychosis
DrugLY03020
Luye Pharma Group Ltd.
Phase 1
40
Beijing
2025-08-20
Active, closed
A Food Effect Study of LY03020 in Healthy Subjects
NCT07292233Schizophrenia, Alzheimer's Disease Psychosis
DrugLY03020
Luye Pharma Group Ltd.
Phase 1
16
Beijing
2025-07-30
Recruiting
Central South University
Phase 3
400
Zhumadian, Changsha, Yueyang, Dali, Xiangshan
2025-07-01
Recruiting
Shanghai Mental Health Center
Not applicable
36
Shanghai
2025-02-05
Recruiting
Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia
NCT06673966Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Mental Disorders
Central South University
Observational
200
Changsha
2025-01-10
Recruiting
Central South University
Not applicable
40
Changsha
2024-11-22
Recruiting
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Not applicable
260
Beijing
2024-10-09
Recruiting
China Medical University Hospital
Phase 2
90
2024-09-23
Recruiting
Vigonvita Life Sciences
Phase 1
40
Beijing, Xi’an
2024-07-16
Recruiting
Sir Run Run Shaw Hospital
Not applicable
100
Hanzhou, Quzhou
2024-04-01
Recruiting
Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents
NCT06904079Severe Mental Disorder, Schizophrenia, Schizoaffective Disorder, Paranoid Psychosis
Shanghai Mental Health Center
Not applicable
82
Shanghai
2024-03-12
By invitation
Tianjin Anding Hospital
Observational
200
Tianjin
2024-02-19
Recruiting
Central South University
Observational
2,000
Hefei, Zhengzhou, Changsha, Nanjing
2024-01-01
Recruiting
App and Body Fat Scale in the Management of Overweight Patients
NCT05866107Schizophrenia, Bipolar Disorder, Metabolic Syndrome, Overweight and Obesity
Capital Medical University
Not applicable
204
Beijing
2023-10-31
Active, closed
Vigonvita Life Sciences
Phase 1
82
Beijing
2023-10-27
Recruiting
China Medical University Hospital
Phase 2
90
2023-10-12
By invitation
Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms
NCT07356765Schizophrenia, Negative Symptoms of Schizophrenia
DrugBerberine
Tianjin Anding Hospital
Not applicable
120
Tianjin
2023-09-26
Recruiting
Central South University
Not applicable
60
Changsha, Dali
2023-08-01
Recruiting
Tianjin Anding Hospital
Observational
300
Tianjin
2022-11-11
Recruiting
China Medical University Hospital
Phase 2
80
2022-02-23
Recruiting
Shanghai Mental Health Center
Observational
1,200
Shanghai
2021-12-01
Recruiting
China Medical University Hospital
Phase 2
90
2020-11-30
Recruiting
China Medical University Hospital
Phase 2
60
2020-10-13
Active, closed
Ningbo Schizophrenia Cohort
NCT06370793Schizophrenia
Ningbo University
Observational
26,899
Ningbo
2018-07-01
Recruiting
China Medical University Hospital
Phase 2
80
2018-01-01
Recruiting
Shanghai Mental Health Center
Observational
3,000
Shanghai
2010-11
Rows per page Showing 1–46 of 46
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/condition/schizophrenia

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,212 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 46 of those studies listing the condition Schizophrenia.

How many Schizophrenia trials are recruiting in China?

31 of the 46 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 9 have not yet opened recruitment, 4 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Schizophrenia), 46 studies
PhaseStudiesRecruitingShare
Not applicable171337%
Observational10721.7%
Phase 210821.7%
Phase 15210.9%
Phase 3214.3%
Phase 1/2102.2%
Phase 4102.2%

Most active sponsors

Lead sponsors with the most studies (Schizophrenia)
Lead sponsorStudiesRecruiting
Central South University76
China Medical University Hospital77
Shanghai Mental Health Center76
Luye Pharma Group Ltd.31
Tianjin Anding Hospital31
Vigonvita Life Sciences31
Anhui Medical University21
Second Xiangya Hospital of Central South University22
Capital Medical University11
Chinese University of Hong Kong10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.